Based in the United States, Inaedis is a startup.
Inaedis develops scalable biopharmaceutical technology that converts liquid biologics into room-temperature-stable powder and suspension formulations, enabling flexible administration routes such as inhaled, intranasal, and subcutaneous delivery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.